CHRISTUS Health offers new technology to detect, treat lung cancer earlier

CHRISTUS Spohn Hospital Corpus Christi – Shoreline announced today it is now offering a new minimally invasive procedure that will help experts find and diagnose lung cancer earlier.

“This new technology allows us to detect lung cancer early so intervention can start now,” said Dr. Rajeev Narang, pulmonologist for CHRISTUS Spohn Hospital Corpus Christi - Shoreline.

“Often times people learn of their lung cancer after it has already spread. This changes that. Most importantly, our patients have a safer alternative with this minimally invasive approach.”

According to the American Cancer Society, lung cancer is the second most common cancer in both men and women in the U.S. Lung cancer is also the leading cause of death in the U.S, accounting for about one in five of all deaths.

This breakthrough technology is the first of its kind for the Coastal Bend. The Ion Robotic Navigational Bronchoscopy is a robotic tool that allows physicians to obtain more precise biopsies of masses that were previously not accessible by traditional procedures, while also minimizing the risks.

During the procedure, the catheter is inserted through the patient’s mouth and throat, entering their lungs. This reduces the chance of complications.

CHRISTUS Spohn Hospital Corpus Christi – Shoreline utilized the technology for the first time this week. Narang and his team extracted a biopsy from a patient and will work with them on their next steps.

“We are committed to providing our patients with the most innovative and technologically advanced health care,” said Dominic Dominguez, chief executive officer for CHRISTUS Spohn Health System. “I am incredibly proud of our team and that we can now offer this technology to our community. They can receive the care they need right here in the Coastal Bend, without having to travel.”